Recurrent Visceral Leishmaniasis in HIV Co-Infection
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorInstitute of Tropical Medicine, Belgium
About this trial
The aim is (1) to better understand the underlying causes and predispositions for relapse and parasite persistence in visceral leishmaniasis (VL) patients living with HIV and (2) to improve treatment monitoring of this target group in Ethiopia
Eligibility criteria
Qualifiers
VL-HIV infection 1.1. VL: microscopically confirmed parasite presence in spleen or bone marrow tissue at first episode or relapse; for known active chronic cases: decision to treat VL 1.2. HIV: confirmed viral infection (new or past)
≥18 years
Disqualifiers
Not willing to provide written informed consent
Not willing to adhere to the follow-up visits
Mentally or physically incapable to participate in the study (to the discretion of the treating physician)
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Institute of Tropical Medicine, Belgium
Lead sponsor
Armauer Hansen Research Institute, Ethiopia
Collaborator
University of Gondar
Collaborator
Source ClinicalTrials.gov